Immunodiagnostic Systems Holdings receives Queens Award for
25 April 2012
Sunderland-based Immunodiagnostic Systems Holdings plc, a
producer of specialist diagnostic testing kits and instrumentation, has
received the Queen’s Award for Enterprise in International Trade.
The Award is given for the highest levels of excellence
demonstrated by a UK based company. The Enterprise in International
Trade Award recognises businesses that have achieved substantial
growth in overseas earnings and in commercial success.
More than 90% of IDS’ products are exported internationally and
the Company has continually grown its export revenues over the last
six years with net profits increasing from around £1 million in 2006
to £16 million in 2011. IDS is building a global presence with
customers throughout the US, Europe and increasingly in Asia
IDS is focused on the development of very sensitive, highly
specific assays to accurately determine the concentration of
biologically important markers in tiny samples of biological fluids
such as serum, plasma, saliva and urine. The results of such
analyses are of critical importance in the diagnosis of disease, the
monitoring of therapy and to biomedical researchers in their quest
to more fully understand the underlying biology of disease states.
IDS works closely with hospitals, universities and research
institutes to bring their innovative ideas and products to market,
with the goal of introducing new clinical tests for the more
efficient diagnosis of disease.
Ian Cookson, CEO of IDS, said: “This is our third Queen’s Award
and the receipt of the Enterprise in International Trade Award is a
powerful recognition of the dedication of our employees, our growing
customer base around the world and of the excellent science that
underpins our business. It is a privilege to have been recommended
by our Prime Minister, David Cameron and we are delighted to receive
this accolade from Her Majesty The Queen.”